다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

SLRN

ACELYRIN (SLRN)

ACELYRIN Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SLRN

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/12	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
2024/06/05	20:00	GlobeNewswire Inc.	ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024	NASDAQ:SLRN	ACELYRIN Inc
2024/05/29	20:00	GlobeNewswire Inc.	ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024	NASDAQ:SLRN	ACELYRIN Inc
2024/05/29	06:20	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:SLRN	ACELYRIN Inc
2024/05/25	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/05/25	08:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/05/25	08:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/05/18	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/05/18	08:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/05/18	08:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/05/15	05:22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SLRN	ACELYRIN Inc
2024/05/09	21:14	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SLRN	ACELYRIN Inc
2024/05/09	21:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
2024/05/09	21:01	GlobeNewswire Inc.	ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones	NASDAQ:SLRN	ACELYRIN Inc
2024/05/09	21:00	GlobeNewswire Inc.	ACELYRIN, INC. Announces Leadership Transition	NASDAQ:SLRN	ACELYRIN Inc
2024/04/30	05:05	GlobeNewswire Inc.	ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024	NASDAQ:SLRN	ACELYRIN Inc
2024/03/29	05:05	GlobeNewswire Inc.	ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights	NASDAQ:SLRN	ACELYRIN Inc
2024/03/28	05:01	GlobeNewswire Inc.	Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million	NASDAQ:SLRN	ACELYRIN Inc
2024/03/20	20:00	GlobeNewswire Inc.	ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease	NASDAQ:SLRN	ACELYRIN Inc
2024/03/11	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
2024/03/11	21:02	GlobeNewswire Inc.	ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis	NASDAQ:SLRN	ACELYRIN Inc
2024/03/11	21:00	GlobeNewswire Inc.	ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients	NASDAQ:SLRN	ACELYRIN Inc
2024/02/16	06:05	GlobeNewswire Inc.	ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications	NASDAQ:SLRN	ACELYRIN Inc
2024/01/12	19:45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)	NASDAQ:SLRN	ACELYRIN Inc
2024/01/12	08:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/01/12	08:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
2024/01/05	19:45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)	NASDAQ:SLRN	ACELYRIN Inc
2023/12/21	06:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
2023/12/21	06:30	GlobeNewswire Inc.	ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors	NASDAQ:SLRN	ACELYRIN Inc
2023/12/18	19:45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)	NASDAQ:SLRN	ACELYRIN Inc

검색 관련기사 보기:NASDAQ:SLRN

1 2 3 다음 >>

Invesco QQQ Trust Series 1

JP Morgan Chase

BNP Paribas (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관